Genetic susceptibility to hepatoxicity due to bosentan treatment in pulmonary hypertension
Journal Title: Annals of Hepatology - Year 2014, Vol 13, Issue 6
Abstract
Background. Hepatotoxicity is a major side effect of treatment with bosentan in patients with pulmonary hypertension (PH). Bosentan is metabolized by the cytochrome CYP2C9 and inhibits the bile salt export pump, which is encoded by ABCB11. This suggests that genetic variants of CYP2C9 and/or ABCB11 may predispose patients to bosentan-induced liver injury. Material and methods. PH patients with (n = 23) or without (n = 25) an increase of alanine aminotransferase (ALT) or aspartate-aminotransferase (AST) during bosentan therapy were included in our analysis. Functionally relevant alleles of CYP2C9 and 16 representative variants of ABCB11 were genotyped. Data were analyzed using logistic regression. Results. Variants of ABCB11 were not associated with bosentan-induced liver injury. In contrast, variant alleles of CYP2C9 were more common in patients with elevated transaminases (allele frequency 52%) compared to controls (allele frequency 24%, P = 0.04, odds ratio 3.5, 95% confidence interval 1.01-11.8). Conclusion. Our data indicate hepatotoxicity of bosentan from decreased hepatic metabolism due to common variants of CYP2C9.
Authors and Affiliations
Hans-Jürgen Seyfarth, Nadine Favreau, Carsten Tennert, Claudia Ruffert, Michael Halank, Hubert Wirtz, Joachim Mössner, Jonas Rosendahl, Peter Kovacs, Henning Wittenburg
Keywords
Related Articles
- EP ID EP78457
- DOI -
- Views 125
- Downloads 0
Effectiveness of add-on Pegylated interferon alfa-2a therapy in a Lamivudine-treated patient with chronic hepatitis B
Hepatitis B virus (HBV) surface antigen (HBsAg) to anti-HBsAg (anti-HBs) antibody seroconversion is the best, final objective for all available chronic hepatitis B (CHB) treatments. Unfortunately, this goal is rarely obt...
Recurrent giant cell hepatitis in an 18 year old liver transplant patient
Idiopathic portal hypertension with multiple hepatic hyperplastic nodules supplied by portal vein
Prognostic markers in cirrhotic patients requiring intensive care: a comparative prospective study
Introduction. The use of prognostic models for cirrhotic patients admitted to the medical intensive care unit (ICU) is of great importance, since they provide an objective evaluation for a group of patients with high mo...
Noncirrhotic Portal Hypertension: Another cause of liver disease in HIV patients